Release Forms:

The composition 1 tablets:

  • active substance: vinpocetine;
  • 1 tablet contains 5 mg of vinpocetine;
  • excipients: lactose, monohydrate; corn starch; magnesium stearate.
10 tablets in a blister; 2 or 3 or 5 blisters in a box.

10 tablets in a blister; 2 or 3 or 5 blisters in a box.

Neurology. For the treatment of various forms of cerebrovascular pathology: conditions after suffering a cerebrovascular accident (stroke), vertebrobasilar insufficiency, vascular dementia, cerebral atherosclerosis, post-traumatic and hypertensive encephalopathy. Helps to reduce mental and neurological symptoms in cerebrovascular pathology. Ophthalmology. For the treatment of chronic vascular pathology of the choroid and retina. Otorhinolaryngology. For the treatment of senile hearing loss of the perceptual type, Meniere’s disease and tinnitus.

Hypersensitivity to vinpocetine or to any component of the drug. Severe ischemic heart disease, cardiac arrhythmias. The period of pregnancy or lactation. Childhood.

The tablets are taken orally after a meal. The dose for adults is 5-10 mg 3 times a day (15-30 mg). In case of liver and / or kidney diseases, special dose selection is not necessary. The duration of treatment is determined by the doctor individually.

The drug is not used in children (due to the lack of clinical data).